Journal List > Allergy Asthma Respir Dis > v.4(4) > 1059193

TOOLS
Lee, Doh, Lee, Park, Oh, Lee, Hong, Lee, Park, Nahm, Yum, and KAACI Work Group on Severe/Recalcitrant Atopic Dermatitis: Multicenter questionnaires on the current management of atopic dermatitis in Korea
Original Article

Allergy, Asthma & Respiratory Disease 2016; 4(4): 271-275.

Published online: 31 July 2016

DOI: https://doi.org/10.4168/aard.2016.4.4.271

Multicenter questionnaires on the current management of atopic dermatitis in Korea

Dong Hun Lee1, *, Eun Jin Doh1, *, Jin Young Lee2, Yang Park3, Jae Won Oh4, Mi Hee Lee5, Soo Jong Hong6, So-Yeon Lee7, Joon Soo Park8, Dong-Ho Nahm9, Hye Yung Yum10; KAACI Work Group on Severe/Recalcitrant Atopic Dermatitis

1Department of Dermatology, Institute of Human-Environment Interface Biology, Seoul National University College of Medicine, Seoul, Korea.

2Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.

3Department of Pediatrics, Wonkwang University Sanbon Hospital, Wonkwang University School of Medicine, Gunpo, Korea.

4Department of Pediatrics, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

5Department of Pediatrics, Incheon Medical Center, Incheon, Korea.

6Department of Pediatrics, University of Ulsan College of Medicine, Seoul, Korea.

7Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.

8Department of Pediatrics, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.

9Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, Korea.

10Department of Pediatrics, Seoul Medical Center, Seoul, Korea.

Correspondence to: Hye Yung Yum. Department of Pediatrics, Seoul Medical Center, 156 Sinnae-ro, Jungnang-gu, Seoul 02053, Korea. Tel: +82-2-2276-7361, Fax: +82-2-2276-7377, hyyum@hanmail.net

Equal contributor:

*These authors contributed equally to this study and should be considered co-first authors.

Received 14 December 2015       Revised 13 February 2016       Accepted 25 February 2016

© 2016 The Korean Academy of Pediatric Allergy and Respiratory Disease; The Korean Academy of Asthma, Allergy and Clinical Immunology

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).

Abstract

Purpose

The effective management of atopic dermatitis (AD) adjusted to individual clinical courses and demands can be challenging to both patients and physicians. Understanding of actual situations, experienced and perceived by patients with AD and their caregivers, is essential to improve clinical outcomes and satisfaction in real practice.

Methods

This multicenter survey was conducted in patients with AD or their caregivers from 9 centers with questionnaires on diagnosis and management of AD.

Results

A total of 324 patients and caregivers participated in the study. Most of the AD cases were initially diagnosed by physicians (80.6%), followed by self-diagnosis. Patients and caregivers thought that allergic substances, such as house dust mites, food, and pollutants, are responsible for AD development; moisturization, environmental control, and improvement of the body constitution are important for AD management. Allergy tests were performed in 194 patients (59.9%), but allergen avoidance strategy was instructed in only 81 subjects (41.8%). Major topical medications were steroids (81.8%) and topical immunomodulators (34.3%), while systemic medications were steroids (42.6%), antihistamines (36.4%), and cyclosporins (2.8%). One hundred eighty-one subjects (55.9%) had received complementary alternative medicine, including Oriental medicine. Many subjects desired to receive individualized management, use of specialized institutions for AD as well as evidence-based, effective, sustainable treatment.

Conclusion

Our findings suggest that there may still be an unmet need for patients with AD in real practice. Personalized, evidencebased, and multidisciplinary approaches, including patient education, should be implemented for good outcomes.

Keywords: Atopic dermatitis, Management, Questionnaire

Figures and Tables

Fig. 1

The source of information about atopic dermatitis.

aard-4-271-g001
Fig. 2

Subjective priority items in management of atopic dermatitis.

aard-4-271-g002
Fig. 3

The use of therapeutic agents according to the severity based on subjective scoring. TCI, topical calcineurin inhibitors; TCS, topical corticosteroids; CAM, complementary alternative medicine.

aard-4-271-g003

References

1. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001; 56:813–824.
crossref
2. Hanifin JM, Reed ML. Eczema Prevalence and Impact Working Group. A population-based survey of eczema prevalence in the United States. Dermatitis. 2007; 18:82–91.
crossref
3. Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013; 131:295–299.e1-27.
4. Park JS, Kim BJ, Park Y, Lee SY, Kim WK, Kim JE, et al. KAAACI Work Group report on the treatment of severe/recalcitrant atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2010; 30:255–270.
5. Proudfoot LE, Powell AM, Ayis S, Barbarot S, Baselga Torres E, Deleuran M, et al. The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey. Br J Dermatol. 2013; 169:901–909.
crossref
6. Kim HB, Cho YJ, Yoo KH, Kim DY, Kim J, Kim H, et al. Survey on the management of atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2012; 32:16–20.
7. Park Y. Status of clinical practice on diagnosis and management of atopic dermatitis in Korea: a questionnaire survey of physicians. Allergy Asthma Respir Dis. 2013; 1:257–265.
crossref
8. Barbarot S, Bernier C, Deleuran M, De Raeve L, Eichenfield L, El Hachem M, et al. Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendations. Pediatr Dermatol. 2013; 30:199–206.
crossref
9. Rubel D, Thirumoorthy T, Soebaryo RW, Weng SC, Gabriel TM, Villafuerte LL, et al. Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective. J Dermatol. 2013; 40:160–171.
crossref
10. Kim JE, Lee YB, Lee JH, Kim HS, Lee KH, Park YM, et al. Disease awareness and management behavior of patients with atopic dermatitis: a questionnaire survey of 313 patients. Ann Dermatol. 2015; 27:40–47.
crossref
11. Cho SE, Jeon JE, Cho H, Son DK, Kim HO, Lee SH, et al. Psychological Intervention in an integrated health care service for children with atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2010; 30:100–109.
12. Segal AO, Ellis AK, Kim HL. CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults. Allergy Asthma Clin Immunol. 2013; 9:24.
crossref
13. Saavedra JM, Boguniewicz M, Chamlin S, Lake A, Nedorost S, Czerkies LA, et al. Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United States. J Pediatr. 2013; 163:1747–1753.
crossref
14. Mohan GC, Lio PA. Comparison of dermatology and allergy guidelines for atopic dermatitis management. JAMA Dermatol. 2015; 151:1009–1013.
crossref
TOOLS
ORCID iDs

Hye Yung Yum
https://orcid.org/http://orcid.org/0000-0002-3997-4094

Similar articles